GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Return-on-Tangible-Asset

Accustem Sciences (Accustem Sciences) Return-on-Tangible-Asset : -2,278.92% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Accustem Sciences's annualized Net Income for the quarter that ended in Mar. 2024 was $-2.11 Mil. Accustem Sciences's average total tangible assets for the quarter that ended in Mar. 2024 was $0.09 Mil. Therefore, Accustem Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was -2,278.92%.

The historical rank and industry rank for Accustem Sciences's Return-on-Tangible-Asset or its related term are showing as below:

ACUT' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -758.7   Med: -390.23   Max: -381.94
Current: -758.7

During the past 2 years, Accustem Sciences's highest Return-on-Tangible-Asset was -381.94%. The lowest was -758.70%. And the median was -390.23%.

ACUT's Return-on-Tangible-Asset is ranked worse than
97.49% of 1551 companies
in the Biotechnology industry
Industry Median: -40.01 vs ACUT: -758.70

Accustem Sciences Return-on-Tangible-Asset Historical Data

The historical data trend for Accustem Sciences's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences Return-on-Tangible-Asset Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23
Return-on-Tangible-Asset
-398.51 -381.94

Accustem Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only -560.94 -422.07 -668.34 -502.04 -2,278.92

Competitive Comparison of Accustem Sciences's Return-on-Tangible-Asset

For the Biotechnology subindustry, Accustem Sciences's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accustem Sciences's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Accustem Sciences's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Accustem Sciences's Return-on-Tangible-Asset falls into.



Accustem Sciences Return-on-Tangible-Asset Calculation

Accustem Sciences's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-2.051/( (0.94+0.134)/ 2 )
=-2.051/0.537
=-381.94 %

Accustem Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-2.108/( (0.134+0.051)/ 2 )
=-2.108/0.0925
=-2,278.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Accustem Sciences  (OTCPK:ACUT) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Accustem Sciences Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Accustem Sciences (Accustem Sciences) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001
Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.

Accustem Sciences (Accustem Sciences) Headlines